Wall Street is trying to figure out whether the U.S. insurance industry will bear any costs from a record $4.69 billion judgment against Johnson & Johnson awarded to customers and their families who claimed that asbestos-contaminated talc caused ovarian cancer.
from Reuters: Top News https://ift.tt/2LD28hM
//
Wednesday, 1 August 2018
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment